Finemedix
파인메딕스 · 387570
Health Care Medical Devices · KOSDAQ
Market cap US$24.9M (₩34.3B)
Overview
Finemedix makes the small, single-use tools that doctors insert through an endoscope to remove tissue, stop bleeding, or clear blockages in the digestive tract, procedures such as mucosal resection, submucosal dissection, and bile-duct stone removal.
Its instruments are supplied to hospitals and clinics in South Korea and internationally. Listed on KOSDAQ, South Korea's tech and small-cap board, the company develops, manufactures, and manages regulatory approval for its full product range in-house, drawing on the clinical background of its chief executive.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2024US$7.2M
- FY2025US$6.9M
Operating profit
- FY2024−US$21.2K
- FY2025−US$1.9M
Net income
- FY2024−US$17.5K
- FY2025−US$1.4M
Key ratios (FY2025)
Why it matters
The company's chief executive brings over two decades of clinical endoscopy experience, which the filing cites as the foundation of its integrated research, regulatory, and manufacturing process.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?